PFIZER, INC.

PFE
Delayed Quote. Delayed  - 09/25 04:10:00 pm
36.05USD +0.81%
Prev.35.7600
Open35.5400
High36.1500
Low35.5200
Volume19 791 158
Latest news
2h ago
5h ago
9h ago
11h ago
Chart PFIZER, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishNeutral
Resistance37,239,340,5
Spread/Res.-3,1%-8,2%-11%
Spread/Supp.1,7%1,7%24%
Support35,535,529,0
Financials
Sales 2020 48 906 M - -
Net income 2020 13 460 M - -
Net Debt 2020 34 671 M - -
P/E ratio 2020 17,1x
Yield 2020 4,20%
Capitalization 200 B 200 B -
EV / Sales 2020 4,81x
EV / Sales 2021 4,11x
Nbr of Employees 88 300
Free-Float 59,1%
Company
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- biopharmaceuticals (76.2%): innovative drugs for the treatment of cancer, inflammatory, autoimmune, infectious, metabolic, cardiovascular and rare diseases, vaccines, etc. In addition,...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2020-11-03 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 42,63 $
Last Close Price 36,05 $
Spread / Highest target 52,6%
Spread / Average Target 18,3%
Spread / Lowest Target -2,91%